Liu Meng, Kong Xiao-Yu, Yao Yuan, Wang Xin-An, Yang Wei, Wu Hui, Li Song, Ding Jia-Wang, Yang Jian
Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Institute of Cardiovascular Diseases, China Three Gorges University, Yichang, China.
Ann Transl Med. 2022 Mar;10(6):368. doi: 10.21037/atm-21-6942.
Ferroptosis is a recently discovered form of cell death which differs from other forms of cell death in terms of morphology, biochemistry, and regulatory mechanisms. Ferroptosis is regulated by a complex system and the precise molecular mechanisms are still being elucidated. Over the past few years, extensive research has revealed that the essence of ferroptosis is iron-dependent accumulation of lipid hydroperoxides induced by oxidative stress, and the System Xc-glutathione (GSH)-glutathione peroxidase 4 (GPX4) pathway is the main ferroptosis prevention system. Meanwhile, other antioxidant systems have also been implicated in regulating ferroptosis, including the transsulfuration pathway, mevalonate pathway, ferroptosis inhibitory protein 1 (FSP1)-Coenzyme Q10 (CoQ10) pathway, dihydroorotate dehydrogenase (DHODH)-dihydroubiquione (CoQH2) pathway, and GTP cyclohydrolase-1 (GCH1)-tetrahydrobiopterin (BH4) pathway. This article reviews the molecular mechanisms of ferroptosis and its critical role in antioxidant systems, aiming to reveal that antioxidation is an important method of inhibiting ferroptosis and to provide a new direction for the treatment of ferroptosis-related diseases.
We searched all original papers and reviews about the molecular mechanisms of ferroptosis in antioxidant systems using PubMed to November 2021. The search terms used included: 'ferroptosis', 'ferroptosis inducers', 'ferroptosis inhibitors', 'ferroptosis and GSH', 'ferroptosis and GPX4', 'ferroptosis and System Xc-', 'SLC7A11', 'P53', 'NRF2 and ferroptosis', 'iron metabolism', 'lipid peroxidation', 'antioxidant systems', 'transsulfuration pathway', 'mevalonate pathway', 'FSP1-CoQ10', 'DHODH-CoQH2', and 'GCH1-BH4'.
We first introduced the origin of ferroptosis and its common inhibitors and inducers. Next, we discussed the molecular mechanisms of ferroptosis and its role in antioxidant systems in existing studies. Finally, we briefly summarized the relationship between ferroptosis and diseases. It reveals that antioxidation is an important method of inhibiting ferroptosis.
This review discusses the recent rapid progress in the understanding of the molecular mechanisms of ferroptosis and its role in several antioxidant systems.
铁死亡是一种最近发现的细胞死亡形式,在形态、生物化学和调节机制方面不同于其他形式的细胞死亡。铁死亡受一个复杂系统调控,其精确的分子机制仍在阐明中。在过去几年里,广泛的研究表明,铁死亡的本质是氧化应激诱导的脂质氢过氧化物的铁依赖性积累,而胱氨酸/谷氨酸逆向转运体-谷胱甘肽(GSH)-谷胱甘肽过氧化物酶4(GPX4)途径是主要的铁死亡预防系统。同时,其他抗氧化系统也参与调节铁死亡,包括转硫途径、甲羟戊酸途径、铁死亡抑制蛋白1(FSP1)-辅酶Q10(CoQ10)途径、二氢乳清酸脱氢酶(DHODH)-二氢泛醌(CoQH2)途径和鸟苷三磷酸环化水解酶-1(GCH1)-四氢生物蝶呤(BH4)途径。本文综述铁死亡的分子机制及其在抗氧化系统中的关键作用,旨在揭示抗氧化是抑制铁死亡的重要方法,并为铁死亡相关疾病的治疗提供新方向。
我们检索了截至2021年11月在PubMed上所有关于铁死亡在抗氧化系统中分子机制的原始论文和综述。使用的检索词包括:“铁死亡”、“铁死亡诱导剂”、“铁死亡抑制剂”、“铁死亡与GSH”、“铁死亡与GPX4”、“铁死亡与胱氨酸/谷氨酸逆向转运体-”、“溶质载体家族7成员11(SLC7A11)”、“P53”、“核因子E2相关因子2(NRF2)与铁死亡”、“铁代谢”、“脂质过氧化”、“抗氧化系统”、“转硫途径”、“甲羟戊酸途径”、“FSP1-CoQ10”、“DHODH-CoQH2”和“GCH1-BH4”。
我们首先介绍了铁死亡的起源及其常见抑制剂和诱导剂。接下来,我们讨论了铁死亡的分子机制及其在现有研究中的抗氧化系统中的作用。最后,我们简要总结了铁死亡与疾病之间的关系。结果表明,抗氧化是抑制铁死亡的重要方法。
本综述讨论了近期在铁死亡分子机制及其在几种抗氧化系统中作用的理解方面取得的快速进展。